Home >> Healthcare >> Food & Beverage >>

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Human Rabies Immunoglobulin (IM) Market 2018, Forecast to 2023

Published: Aug-2018 | Format: PDF | Global Info Research | Number of pages: 133 | Code: MRS - 355294

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Scope of the Report:
This report focuses on the Human Rabies Immunoglobulin (IM) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. It is given after the wound is cleaned with soap and water or providone-iodine and is followed by a course of rabies vaccine.
The use of rabies immunoglobulin in the form of blood serum dates from 1891. Use become common within medicine in the 1950s. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.
The worldwide market for Human Rabies Immunoglobulin (IM) is expected to grow at a CAGR of roughly 7.3% over the next five years, will reach 440 million US$ in 2023, from 290 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
    CSL Behring
    Grifols 
    Sanofi
    Sichuan Yuanda Shuyang
    CNBG
    Kamada
    CBPO
    Shuanglin Bio
    Weiguang Bio
    Shanghai RAAS
    Bharat Serum
    VINS

Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    ERIG
    HRIG

Market Segment by Applications, can be divided into
    Category II Exposure
    Category III Exposure

There are 15 Chapters to deeply display the global Human Rabies Immunoglobulin (IM) market.
Chapter 1, to describe Human Rabies Immunoglobulin (IM) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Rabies Immunoglobulin (IM), with sales, revenue, and price of Human Rabies Immunoglobulin (IM), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Rabies Immunoglobulin (IM), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Rabies Immunoglobulin (IM) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Rabies Immunoglobulin (IM) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents

1 Market Overview
    1.1 Human Rabies Immunoglobulin (IM) Introduction
    1.2 Market Analysis by Type
        1.2.1 ERIG
        1.2.2 HRIG
    1.3 Market Analysis by Applications
        1.3.1 Category II Exposure
        1.3.2 Category III Exposure
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2013-2023)
            1.4.1.2 Canada Market States and Outlook (2013-2023)
            1.4.1.3 Mexico Market States and Outlook (2013-2023)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2013-2023)
            1.4.2.2 France Market States and Outlook (2013-2023)
            1.4.2.3 UK Market States and Outlook (2013-2023)
            1.4.2.4 Russia Market States and Outlook (2013-2023)
            1.4.2.5 Italy Market States and Outlook (2013-2023)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2013-2023)
            1.4.3.2 Japan Market States and Outlook (2013-2023)
            1.4.3.3 Korea Market States and Outlook (2013-2023)
            1.4.3.4 India Market States and Outlook (2013-2023)
            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2013-2023)
            1.4.4.2 Egypt Market States and Outlook (2013-2023)
            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
            1.4.4.4 South Africa Market States and Outlook (2013-2023)
            1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 CSL Behring
        2.1.1 Business Overview
            2.1.1.1 CSL Behring Description
            2.1.1.2 CSL Behring Headquarter, Main Business and Finance Overview
        2.1.2 CSL Behring Human Rabies Immunoglobulin (IM) Product Introduction
            2.1.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.1.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.1.3.1 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.1.3.2 Global CSL Behring Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.2 Grifols 
        2.2.1 Business Overview
            2.2.1.1 Grifols  Description
            2.2.1.2 Grifols  Headquarter, Main Business and Finance Overview
        2.2.2 Grifols  Human Rabies Immunoglobulin (IM) Product Introduction
            2.2.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.2.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.2.3 Grifols  Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.2.3.1 Grifols  Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.2.3.2 Global Grifols  Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.3 Sanofi
        2.3.1 Business Overview
            2.3.1.1 Sanofi Description
            2.3.1.2 Sanofi Headquarter, Main Business and Finance Overview
        2.3.2 Sanofi Human Rabies Immunoglobulin (IM) Product Introduction
            2.3.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.3.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.3.3.1 Sanofi Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.3.3.2 Global Sanofi Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.4 Sichuan Yuanda Shuyang
        2.4.1 Business Overview
            2.4.1.1 Sichuan Yuanda Shuyang Description
            2.4.1.2 Sichuan Yuanda Shuyang Headquarter, Main Business and Finance Overview
        2.4.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Introduction
            2.4.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.4.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.4.3.1 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.4.3.2 Global Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.5 CNBG
        2.5.1 Business Overview
            2.5.1.1 CNBG Description
            2.5.1.2 CNBG Headquarter, Main Business and Finance Overview
        2.5.2 CNBG Human Rabies Immunoglobulin (IM) Product Introduction
            2.5.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.5.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.5.3.1 CNBG Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.5.3.2 Global CNBG Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.6 Kamada
        2.6.1 Business Overview
            2.6.1.1 Kamada Description
            2.6.1.2 Kamada Headquarter, Main Business and Finance Overview
        2.6.2 Kamada Human Rabies Immunoglobulin (IM) Product Introduction
            2.6.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.6.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.6.3.1 Kamada Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.6.3.2 Global Kamada Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.7 CBPO
        2.7.1 Business Overview
            2.7.1.1 CBPO Description
            2.7.1.2 CBPO Headquarter, Main Business and Finance Overview
        2.7.2 CBPO Human Rabies Immunoglobulin (IM) Product Introduction
            2.7.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.7.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.7.3.1 CBPO Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.7.3.2 Global CBPO Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.8 Shuanglin Bio
        2.8.1 Business Overview
            2.8.1.1 Shuanglin Bio Description
            2.8.1.2 Shuanglin Bio Headquarter, Main Business and Finance Overview
        2.8.2 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Introduction
            2.8.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.8.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.8.3.1 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.8.3.2 Global Shuanglin Bio Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.9 Weiguang Bio
        2.9.1 Business Overview
            2.9.1.1 Weiguang Bio Description
            2.9.1.2 Weiguang Bio Headquarter, Main Business and Finance Overview
        2.9.2 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Introduction
            2.9.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.9.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.9.3.1 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.9.3.2 Global Weiguang Bio Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.10 Shanghai RAAS
        2.10.1 Business Overview
            2.10.1.1 Shanghai RAAS Description
            2.10.1.2 Shanghai RAAS Headquarter, Main Business and Finance Overview
        2.10.2 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Introduction
            2.10.2.1 Human Rabies Immunoglobulin (IM) Production Bases, Sales Regions and Major Competitors
            2.10.2.2 Human Rabies Immunoglobulin (IM) Product Information
        2.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.10.3.1 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.10.3.2 Global Shanghai RAAS Human Rabies Immunoglobulin (IM) Market Share in 2017
    2.11 Bharat Serum
        2.11.1 Business Overview
        2.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Product Introduction
        2.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 VINS
        2.12.1 Business Overview
        2.12.2 VINS Human Rabies Immunoglobulin (IM) Product Introduction
        2.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Rabies Immunoglobulin (IM) Market Competition, by Manufacturer
    3.1 Global Human Rabies Immunoglobulin (IM) Sales and Market Share by Manufacturer (2016-2017)
    3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Global Human Rabies Immunoglobulin (IM) Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Human Rabies Immunoglobulin (IM) Manufacturer Market Share in 2017
        3.4.2 Top 5 Human Rabies Immunoglobulin (IM) Manufacturer Market Share in 2017
    3.5 Market Competition Trend
4 Global Human Rabies Immunoglobulin (IM) Market Analysis by Regions
    4.1 Global Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Regions
        4.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Regions (2013-2018)
        4.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Regions (2013-2018)
    4.2 North America Human Rabies Immunoglobulin (IM) Sales, Revenue and Growth Rate (2013-2018)
    4.3 Europe Human Rabies Immunoglobulin (IM) Sales, Revenue and Growth Rate (2013-2018)
    4.4 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales, Revenue and Growth Rate (2013-2018)
    4.5 South America Human Rabies Immunoglobulin (IM) Sales, Revenue and Growth Rate (2013-2018)
    4.6 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales, Revenue and Growth Rate (2013-2018)
5 North America Human Rabies Immunoglobulin (IM) by Countries, Type, Application and Manufacturers
    5.1 North America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Countries
        5.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Countries (2013-2018)
        5.1.2 North America Human Rabies Immunoglobulin (IM) Revenue by Countries (2013-2018)
        5.1.3 United States Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        5.1.4 Canada Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        5.1.5 Mexico Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
    5.2 North America Human Rabies Immunoglobulin (IM) Sales and Revenue (Value) by Manufacturers (2016-2017)
        5.2.1 North America Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2016-2017)
        5.2.2 North America Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2017)
    5.3 North America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Type (2013-2018)
        5.3.1 North America Human Rabies Immunoglobulin (IM) Sales and Sales Share by Type (2013-2018)
        5.3.2 North America Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Type (2013-2018)
    5.4 North America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Application (2013-2018)
        5.4.1 North America Human Rabies Immunoglobulin (IM) Sales and Sales Share by Application (2013-2018)
        5.4.2 North America Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Application (2013-2018)
6 Europe Human Rabies Immunoglobulin (IM) by Countries, Type, Application and Manufacturers
    6.1 Europe Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Countries
        6.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Countries (2013-2018)
        6.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Countries (2013-2018)
        6.1.3 Germany Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        6.1.4 UK Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        6.1.5 France Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        6.1.6 Russia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        6.1.7 Italy Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
    6.2 Europe Human Rabies Immunoglobulin (IM) Sales and Revenue (Value) by Manufacturers (2016-2017)
        6.2.1 Europe Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2016-2017)
        6.2.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2017)
    6.3 Europe Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Type (2013-2018)
        6.3.1 Europe Human Rabies Immunoglobulin (IM) Sales and Sales Share by Type (2013-2018)
        6.3.2 Europe Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Type (2013-2018)
    6.4 Europe Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Application (2013-2018)
        6.4.1 Europe Human Rabies Immunoglobulin (IM) Sales and Sales Share by Application (2013-2018)
        6.4.2 Europe Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Human Rabies Immunoglobulin (IM) by Countries, Type,  Application and Manufacturers
    7.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Countries (2013-2018)
        7.1.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Countries (2013-2018)
        7.1.3 China Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        7.1.4 Japan Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        7.1.5 Korea Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        7.1.6 India Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        7.1.7 Southeast Asia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
    7.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales and Revenue (Value) by Manufacturers (2016-2017)
        7.2.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2016-2017)
        7.2.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2017)
    7.3 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Type (2013-2018)
        7.3.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales and Sales Share by Type (2013-2018)
        7.3.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Type (2013-2018)
    7.4 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Application (2013-2018)
        7.4.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales and Sales Share by Application (2013-2018)
        7.4.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Application (2013-2018)
8 South America Human Rabies Immunoglobulin (IM) by Countries, Type, Application and Manufacturers
    8.1 South America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Countries
        8.1.1 South America Human Rabies Immunoglobulin (IM) Sales by Countries (2013-2018)
        8.1.2 South America Human Rabies Immunoglobulin (IM) Revenue by Countries (2013-2018)
        8.1.3 Brazil Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        8.1.4 Argentina Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        8.1.5 Colombia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
    8.2 South America Human Rabies Immunoglobulin (IM) Sales and Revenue (Value) by Manufacturers (2016-2017)
        8.2.1 South America Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2016-2017)
        8.2.2 South America Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2017)
    8.3 South America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Type (2013-2018)
        8.3.1 South America Human Rabies Immunoglobulin (IM) Sales and Sales Share by Type (2013-2018)
        8.3.2 South America Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Type (2013-2018)
    8.4 South America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Application (2013-2018)
        8.4.1 South America Human Rabies Immunoglobulin (IM) Sales and Sales Share by Application (2013-2018)
        8.4.2 South America Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Human Rabies Immunoglobulin (IM) by Countries, Type, Application and Manufacturers
    9.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Countries (2013-2018)
        9.1.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Countries (2013-2018)
        9.1.3 Saudi Arabia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        9.1.4 UAE Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        9.1.5 Egypt Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        9.1.6 Nigeria Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
        9.1.7 South Africa Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2013-2018)
    9.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales and Revenue (Value) by Manufacturers (2016-2017)
        9.2.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2016-2017)
        9.2.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2017)
    9.3 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Type (2013-2018)
        9.3.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales and Sales Share by Type (2013-2018)
        9.3.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Type (2013-2018)
    9.4 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Application (2013-2018)
        9.4.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales and Sales Share by Application (2013-2018)
        9.4.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue and Revenue Share by Application (2013-2018)
10 Global Human Rabies Immunoglobulin (IM) Market Segment by Type
    10.1 Global Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Type (2013-2018)
        10.1.1 Global Human Rabies Immunoglobulin (IM) Sales and Market Share by Type (2013-2018)
        10.1.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2013-2018)
    10.2 ERIG Sales Growth and Price
        10.2.1 Global ERIG Sales Growth (2013-2018)
        10.2.2 Global ERIG Price (2013-2018)
    10.3 HRIG Sales Growth and Price
        10.3.1 Global HRIG Sales Growth (2013-2018)
        10.3.2 Global HRIG Price (2013-2018)
11 Global Human Rabies Immunoglobulin (IM) Market Segment by Application
    11.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2013-2018)
    11.2 Category II Exposure Sales Growth (2013-2018)
    11.3 Category III Exposure Sales Growth (2013-2018)
12 Human Rabies Immunoglobulin (IM) Market Forecast (2018-2023)
    12.1 Global Human Rabies Immunoglobulin (IM) Sales, Revenue and Growth Rate (2018-2023)
    12.2 Human Rabies Immunoglobulin (IM) Market Forecast by Regions (2018-2023)
        12.2.1 North America Human Rabies Immunoglobulin (IM) Market Forecast (2018-2023)
        12.2.2 Europe Human Rabies Immunoglobulin (IM) Market Forecast (2018-2023)
        12.2.3 Asia-Pacific Human Rabies Immunoglobulin (IM) Market Forecast (2018-2023)
        12.2.4 South America Human Rabies Immunoglobulin (IM) Market Forecast (2018-2023)
        12.2.5 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Forecast (2018-2023)
    12.3 Human Rabies Immunoglobulin (IM) Market Forecast by Type (2018-2023)
        12.3.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2018-2023)
        12.3.2 Global Human Rabies Immunoglobulin (IM) Market Share Forecast by Type (2018-2023)
    12.4 Human Rabies Immunoglobulin (IM) Market Forecast by Application (2018-2023)
        12.4.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2018-2023)
        12.4.2 Global Human Rabies Immunoglobulin (IM) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)4880 View Pricing